All Stories

  1. Long-Term Outcomes of Low-Dose-Rate Brachytherapy in Localized Prostate Cancer: A 17-Year Retrospective Analysis of a Single-Center Portuguese Cohort
  2. Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment?
  3. Obesogenic Dysregulation of Human Periprostatic Adipose Tissue Promotes the Viability of Prostate Cells and Reduces Their Sensitivity to Docetaxel and Cabazitaxel
  4. Supratrigonal systectomy: last line treatment for radiation-induced hemorrhagic cystitis
  5. Endocrine-disrupting chemicals as prostate carcinogens
  6. Salvage cryotherapy for prostate cancer
  7. Aptamer-based approaches to detect nucleolin in prostate cancer
  8. Towards the differential diagnosis of prostate cancer by the pre-treatment of human urine using ionic liquids
  9. Consensos em HPV Masculino da Sociedade Portuguesa de Andrologia, Medicina Sexual e Reprodução: Tratamento
  10. Recomendações em HPV Masculino da Sociedade Portuguesa de Andrologia, Medicina Sexual e Reprodução: Prevenção
  11. Consensos em HPV masculino da Sociedade Portuguesa de Andrologia, Medicina Sexual e Reprodução: diagnóstico
  12. European Sexual Medicine Network: a unique platform for collaboration
  13. Complicaciones de la biopsia transrectal de próstata en nuestro medio. Estudio multicéntrico internacional de 3.350 pacientes
  14. Profilaxis farmacológica de la tromboembolia venosa en la prostatectomía radical
  15. Premature Ejaculation – From Physiology to Treatment
  16. Biological principles and clinical application of positron emission tomography-tracers in prostate cancer: a review
  17. 6ER-012 Withdrawn
  18. Pielonefrite Enfisematosa Fulminante Secundária a Neoplasia Urotelial com Fístula Renocólica
  19. Local Treatment of Metastatic Prostate Cancer: What is the Evidence So Far?
  20. Focal therapies for the treatment of localized prostate cancer: The role of irreversible electroporation – Present or future?
  21. Influence of secondary diagnoses in the development of urinary incontinence after radical prostatectomy
  22. The Global Prevalence of Infections in Urology (GPUI) Study: A Worldwide Surveillance Study in Urology Patients
  23. Focal therapies for the treatment of localized prostate cancer: The role of irreversible electroporation – Present or future?
  24. PS-08-001 Sedentary lifestyle, erectile dysfunction and lower urinary tract symptoms
  25. Reply by the Authors
  26. New Therapeutic Perspectives in Premature Ejaculation
  27. The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections
  28. 255 Infective complications after prostate biopsy: Outcome of the Global Prevalence of Infections in Urology (GPIU) prostate biopsy side study 2010 – 2013. A prospective, multinational, multicenter study
  29. P044 Factors related with urinary incontinence grade after radical prostatectomy
  30. P058 Relationship between tumour burden in the transrectal biopsy and positive margins in radical prostatectomy
  31. Mechanisms of male infertility in autosomal dominant polycystic kidney disease
  32. 449 Clinical properties of multi & extensive drug resistance Enterobacteriaceae in urosepsis: Outcome of the global prevalence of infections in urology (GPIU) study: 9 Year results of a multinational, multicenter study
  33. Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study
  34. Pararenal sclerosing PEComa
  35. Infective Complications After Prostate Biopsy: Outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, A Prospective Multinational Multicentre Prostate Biopsy Study
  36. Antibiotic Prophylaxis in Urology Departments, 2005–2010
  37. Adrenal ganglioneuroma: a rare incidental finding
  38. Large Cell Neuroendocrine Carcinoma of the Urinary Bladder: Case Report and Review
  39. Coagulum Pyelolithotomy “Revisited” by Laparoscopy: Technique Modification
  40. Benign Prostate Hyperplasia and Chronic Kidney Disease
  41. 297 Multi-drug resistant hospital acquired urinary tract isolates: Prevalence and demographic properties: Outcome of the Global Prevalence of Infections in Urology (GPIU) Study: Six year results of a multinational, multicenter study
  42. 37 Infective complications after prostate biopsy: Outcome of the Global Prevalence of Infections in Urology (GPIU) prostate biopsy side study 2010 – a multinational, multicenter study
  43. Ectopic Scrotum: A Rare Clinical Entity
  44. Metanephric Adenoma of the Kidney: Can We Take a Step Forward in a Presurgery Diagnosis?
  45. Retroperitoneum Beyond the Kidney: Retroperitoneal Sarcomas in a Urology Department
  46. C2 PROSTATE-SPECIFIC ANTIGEN LEVELS « 4 NG/ML – THERE ARE PREDICTIVE FACTORS FOR PROSTATE CANCER?
  47. C84 WHITE LIGHT AND NBI-ASISTED TURBT
  48. UP-01.028 Narrow Band Imaging (NBI) Assisted TURBt. Does It Improve Detection and Treatment Rates?
  49. UP-01.046 Intravesical Bacillus Calmette-Guérin Immunotherapy: The Experience of the Centro Hospitalar De Coimbra Urology Department
  50. UP-01.158 Metanephric Adenoma: Unusual Renal Neoplasm, 2 Case Reports
  51. UP-01.198 Partial Nephrectomy vs Laparoscopic Radical Nephrectomy Renal Function Outcomes
  52. UP-03.094 Laser Holmium Retrograde Lithotripsy: A Single-Center Experience
  53. Infected urachal cyst in the adult
  54. UP-2.01: Endoscopic removal of spontaneously migrated IUD to the bladder
  55. UP-2.58: Schistosomiasis: unusual cause of LUTS in Europe
  56. Sexual dysfunction in uraemic patients undergoing haemodialysis: predisposing and related conditions
  57. Metabolic Syndrome and Sexual (Dys)function
  58. Zinner’s syndrome: an up-to-date review of the literature based on a clinical case